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Abstract: New clerodane diterpenes, 12-epi-megalocarpodolide D (2) and an epimeric
mixture of crotonolins A (3) and B (4), were isolated from the bark of Croton oligandrus
following a bioassay-guided isolation protocol. Known compounds, megalocarpodolide D
(1), 12-epi-crotocorylifuran (5), cluytyl-ferulate (6), hexacosanoyl- ferulate (7), vanillin (8),
acetyl-aleuritolic acid (9) and lupeol (10), were also isolated. The structures of the isolated compounds
(1–10) were elucidated by spectroscopic means. The cytotoxicity of compounds 1–10 was assessed
against A549, MCF7, PC3 and PNT2 cell lines using the MTT assay. Compounds 1 and 2 showed
moderate levels of activity against both A549 and MCF7 cells with 1 being the most active with IC50
values of 63.8 ± 13.8 and 136.2 ± 22.7 µM against A549 and MCF7 cells, respectively. The epimeric
mixture of 3 and 4 was moderately active against A549 and PC3 cells (IC50 = 128.6 ± 31.0 and
111.2 ± 2.9 µM, respectively).
Keywords: Croton oligandrus; Euphorbiaceae; ent-clerodanes; crotonolin A; crotonolin B; cytotoxicity
1. Introduction
The genus Croton L. belongs to the spurge family Euphorbiaceae, which is one of the largest
families of flowering plants with about 300 genera and more than 7500 species [1]. This family has five
subfamilies: Acalyphoideae, Crotonoideae, Euphorbioideae, Phyllanthoideae and Oldfieldoiideae [2].
The genus Croton L. belongs to the Crotonoideae subfamily, and comprises around 1300 species of
herbs, shrubs and trees growing in tropical and subtropical regions of the globe [3]. The species of this
genus have long been used in ethnomedicine. In the Ayurvedic system of medicine, Croton oblongifolius
Roxb. and Croton tiglium L. have been mentioned for their use in the treatment of liver diseases,
sprains and snake bites, as well as a purgative, since 2000 BC [4]. Croton tiglium has also been used in
Chinese Traditional Medicine (TCM) to treat severe constipation. Popular traditional uses of Croton
species include their use in the treatment of cancer, constipation, diabetes, fever, hypercholesterolemia,
hypertension, inflammation, malaria, pain and weight-loss [5–10]. Croton oligandrus Pierre ex Hutch. is
a tree (5–10 m high), commonly found in Western and Central African forests, especially in Cameroon
and Gabon [11,12]. The stem bark decoction of C. oligandrus is taken orally in Cameroon to treat
anaemia, pneumonia and splenomegaly [12–14]. Agnaniet et al. identified linalool as the main
constituent of the essential oil of the species collected in Gabon, and showed that the oil possessed
neither good antioxidants nor antiradical activity [15]. Further, studies of the species harvested in
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Cameroon revealed the presence of clerodane-type diterpenes as the main class of metabolites [16].
Clerodane diterpenes are widely distributed within the genus Croton, and known to possess antifeedant,
cytotoxic and antiprotozoal properties [17]. As part of our ongoing research into bioactive compounds
from Cameroonian medicinal plants [18,19], we shall report on the isolation of three new clerodane
diterpenes (2–4), together with known compounds 1 and 5–10 (Figure 1), and assess their cytotoxicity
against human cancer cell lines.
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2. Results and Discussion
The n-hexane, DCM and MeOH extracts obtained from the bark of C. oligandrus were screened for
their cytotoxic activity (Table 1). While the MeOH extract was devoid of any cytotoxicity below 250 µg/mL,
the n-hexane extract displayed cyt toxicity against the cell lines, PC3 (human prostate cancer) and MCF7
(human breast adenocarcinoma), with IC50 values of 71.7± 1.5 and 31.5± 0.9 µg/mL, r sp c ively, and
the DCM extract was only active gainst the MCF7 cell line (IC50 = 59.7± 3.0 µg/mL). Fractionation of the
active crude extracts followed by their cytotoxic evaluation identified fractions H1, H2, H4 and H5 of the
n-hexane extract and fractions D1, D2, D3, D4 and D6 from the DCM extract as cytotoxic (Table 1).
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Table 1. Cell growth inhibitory activities of the extracts, fractions and isolated compounds against
cancer and noncancerous (PNT2) cells *.
IC50 Values
Extracts/Fractions (µg/mL) A549 MCF-7 PC-3 PNT2
Hexane extract >250 71.7 ± 1.5 31.5 ± 0.9 nd
DCM extract >250 59.7 ± 3.0 >250 nd
MeOH extract >250 >250 >250 nd
D1 39.5 ± 2.9 106.0 ± 4.2 209.3 ± 7.6 nd
D2 54.9 ± 1.7 20.2 ± 1.2 39.9 ± 2.9 nd
D3 126.8 ± 1.2 52.5 ± 0.5 90.3 ± 0.6 nd
D4 44.4 ± 3.1 52.2 ± 0.3 104.3 ± 4.9 nd
D5 >250 >250 >250 nd
D6 >250 66.2 ± 1.5 >250 nd
H1 147.5 ± 1.5 84.5 ± 5.2 13.2 ± 0.0 nd
H2 102.2 ± 0.9 103.7 ± 4.9 109.3 ± 3.7 nd
H3 >250 173.1 ± 4.9 >250 nd
H4 106.6 ± 6.6 60.6 ± 1.2 211.8 ± 10.1 nd
H5 49.9 ± 5.5 42.7 ± 12.5 >250 nd
H6 >250 150.4 ± 5.9 >250 nd
Compounds (µM)
1 63.8 ± 13.8 136.2 ± 22.7 >200 >200
2 138.6 ± 22.1 171.3 ± 51.4 >200 >200
3/4 128.6 ± 31.0 >200 111.2 ± 2.9 >200
5 106.6 ± 27.2 >200 >200 >200
6/7 >200 >200 160.9 ± 36.2 >200
8 >200 >200 >200 >200
9 136.8 ± 18.9 >200 172.3 ± 39.7 167.5 ± 25.3
10 >200 >200 135.6 ± 21.1 >200
Doxorubicin 1.3 ± 0.3 0.7 ± 0.1 16.4 ± 2.9 1.5 ± 0.3
* Data are represented as mean ± SEM (n = 3); IC50 = sample concentration that caused 50% cell growth inhibition;
nd = not determined.
Phytochemical analysis of the active fractions afforded a mixture (1:1) of ferulate derivatives,
cluytyl-ferulate and hexacosanoyl-ferulate (6 and 7) [20,21], vanillin (8) [22], acetyl-aleuritolic acid (9)
and lupeol (10) [23,24] from the fractions H2, H4 and H5. From the fractions D2 and D3, the mixture
of 6 and 7 was also obtained by recrystallization and the remaining filtrate was found to be a mixture
of 9 and 10. Fractions D4 and D6 were purified by preparative HPLC to afford the known clerodane
diterpenes megalocarpoidolide D (1) and 12-epi-crotocorylifuran (5) [25], and the new clerodanes
12-epi-megalocarpoidolide D (2), and crotonolins A (3) and B (4) (Figure 1). Fractions D1 and H1 showed
a single spot on TLC, but this was found to be a mixture of fatty acids by preliminary 1H NMR and was
not further purified.
Compounds 1 and 2 were isolated as white amorphous powders. Their molecular formula
C22H22O8 was determined from the pseudo molecular ion peak at m/z 432.1650 calculated 432.1653
for C22H22O8NH4 [M + NH4]+, from the HRMS spectrum obtained in positive ion mode. The IR
spectrum of 1 displayed absorption stretching bands at 1715, 1767 and 1663 cm−1 corresponding to the
carbonyl of ester, lactone and ketone groups, respectively. Assignment of 1H and 13C NMR data of 1
(Table 2) was confirmed by its 2D NMR (COSY, HSQC and HMBC) data, and all data were in agreement
with that of the β-substituted furanoclerodane, megalocarpoidolide D (1), previously isolated from
the roots of C. megalacarpoides (C. megalocarpus Hutch.) [25]. In addition, in the NOESY experiment,
a strong correlation was observed between H-12 and H-1 which confirmed the C-12 relative absolute
configuration in 1 to be 12S as published for megalocarpoidolide D (1) [25]. Thus, compound 1 was
identified as the known compound megalocarpoidolide D (1) (Figure 1).
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Table 2. 1H and 13C NMR data a of diterpenes 1–4.
Position
Chemical Shift in ppm
1H (coupling constant J in Hz) 13C
1 b 2 b 3 + 4 c 1 b 2 b 3 + 4 c
1 6.47 br d (1.2), 1H 6.47 d (1.0), 1H 6.91 d (1.2), 1H 127.8 129.1 129.0
2 - - - 185.8 185.7 187.2
3 6.78 d (1.3), 1H 6.78 d (1.0), 1H 6.80 d (1.2), 1H 131.4 130.9 131.7
4 - - - 150.7 151.3 152.4
5 - - - 53.5 55.1 54.3
6
1.45 ddd (3.7, 13.3, 17.5), 1H 1.44 ddd (9.3, 13.5, 17.7), 1H 1.51 ddd (4.0, 13.5, 17.5), 1H
33.1 33.2 33.93.11 dt (3.0, 6.1), 1H 3.12 dt (3.3, 13.3), 1H 3.00 m, 1H
7
1.71 m, 1H 1.65 m, 1H 1.66 m, 1H
26.5 27.2 27.52.78 m, 1H 2.49 ddd (4.2, 13.9, 17.1), 1H 2.66 m, 1H
8 1.75 m, 1H 1.78 m, 1H 1.82 m, 1H 39.7 43.7 40.0
9 - - - 55.0 53.6 55.9
10 - - - 155.4 155.7 156.2
11
2.78 m, 1H 2.69 dd (8.2, 14.3), 1H 2.80 m, 1H
38.9 39.2 36.92.65 dd (11.1, 14.5), 1H 2.94 dd (6.3, 14.2), 1H 2.93 m, 1H
12 5.55 dd (5.2, 11.1), 1H 5.57 t (7.0), 1H 5.72 dd (5.5, 11.1), 1H 71.3 72.0 72.4
13 - - - 123.5 125.0 135.0
14 6.45 m, 1H 6.41 m, 1H 7.40 and 7.39 br s, 1H 108.1 107.8 149.8
15 7.47 br t (1.5, 3.1), 1H 7.49 br d (1.6), 1H 6.20 and 6.18 br s, 1H 144.4 144.6 99.3
16 7.54 br s, 1H 7.45 m, 1H - 140.5 139.7 170.9
17 1.17 d (6.4), 3H 1.23 d (6.7), 3H 1.15 d (5.8), 3H 16.9 17.7 17.1
18 - - - 165.3 165.5 166.7
18-OMe 3.84 s, 3H 3.84 s, 3H 3.71 s, 3H 53.0 52.9 53.3
19 - - - 166.3 166.7 168.4
19-OMe 3.65 s, 3H 3.71 s, 3H 3.60 s, 3H 53.2 53.1 53.7
20 - - - 172.2 173.1 174.0
a All assignments were confirmed unequivocally as based on COSY, HSQC, HMBC and NOESY experiments;
Spectra obtained in: b CDCl3 (300 MHz for 1H and 75 MHz for 13C NMR, respectively) and c CD3OD (600 MHz for
1H and 150 MHz for 13C NMR, respectively).
The 1H and 13C NMR data of compound 2 (Table 2) were similar to those of 1, but with slight
differences (see Supplementary Material). Interpretation of 1H, 13C, COSY, HSQC and HMBC NMR
spectral data of 2 concluded that its core structure was identical to that of 1. However, the NOESY
spectrum showed a strong correlation between H-12 and H-17 (instead of H-1 as in compound 1),
establishing the relative configuration at C-12 in 2—the opposite to that of compound 1. The absolute
configuration at C-12 in 2 could be confirmed as 12R instead of 12S (as in 1). Thus, compound 2 was
identified as a new C-12R epimer of 1 and named 12-epi-megalocarpoidolide D (2) (Figure 1).
Compound 3 and its 15-epimer 4 were isolated as a white amorphous powder mixture with a
molecular formula of C22H22O10, as determined from the HRMS data obtained in the negative ion
mode (m/z 445.1142 [M − H]− calculated 445.1140 for C22H21O10). The IR absorption bands at 3465,
1775, 1712 and 1661 cm−1 could be assigned to the stretch signals of hydroxyl and the carbonyls of
ester, lactone and ketone groups, respectively. The assignment of the 1H and 13C NMR data (Table 2)
was confirmed by the COSY, HSQC and HMBC spectral data analyses. A total of 22 carbon signals
were observed in the 13C NMR spectrum (Table 2). The signals could be assigned to one methyl C-17
(δ 17.1), two methoxyls at δ53.3 and 53.7, six methines including three olefinic carbons at δ129.0, 131.7
and 149.8, ten quaternary carbon signals including an unsaturated ketone at δ187.2 (C-2) and the
carbonyls of two esters at δ166.7 and 168.4 corresponding to C-18 and C-19, respectively. In the 1H
NMR spectrum (Table 2), the 1H doublet at δ5.72 (J = 11.1, 5.5 Hz) could be assigned to H-12 and
the two 1H multiplets at δ2.80 and 2.93, coupling with each other and with H-12 as evident from the
COSY experiment, were assigned to the C-11ax and C-11eq protons, respectively. The doublet at δ1.15
(3H, J = 5.8 Hz) was assigned to C-17 and the corresponding coupled methine signal at δ1.82 was
assigned to C-8. The C-6 and C-7 methylene protons were assigned to protons resonating at δ1.51
(ddd, J = 4.0, 13.5, 17.5 Hz), 3.00 (m) and 1.66 (m), 2.66 ppm (m), respectively. The olefinic protons
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at δ6.91 (d, J = 1.2 Hz) and 6.80 (d, J = 1.2 Hz) were assigned to protons C-1 and C-3, respectively.
This assignment was consistent with the different correlations observed in the HMBC experiment.
The 1H and 13C NMR data of 3 and 4 were similar to those of compound 1 and 2, but there were no
signals for protons of the furan ring, suggesting that the furan rings in 3 and 4 were modified. In the
1H NMR spectrum (Table 2), there were two doublets at δ6.19 and 7.40 for methines showing cross
peak correlation in the HSQC spectrum with carbon signals at δ 99.3 and 149.8, respectively. These two
methines, in the HMBC experiment, showed a strong correlation with a deshielded carbon signal at
δ170.9. The above NMR data were similar to those of the modified furan ring present in salvidinin
B, a clerodane diterpene isolated from Salvia divinorum [26]. The hemiacetal carbon C-15 was then
attributed to the signal at δ99.3 ppm, the olefinic carbon C-14 at δ149.8 ppm, the carbonyl C-16 at
δ170.9 ppm and C-13 at δ135.0 ppm. These attributions were supported by the correlation between
the proton signal at δ7.40 (H-14) and the carbon C-12, and correlations between protons H-12 and
H-11eq with C-13 observed in the HMBC experiment. However, the signals attributed to protons
H-14 and H-15 were not broad singlets like in similar molecular cases [26–28]. In addition, the two
protons did not show any correlation in the COSY experiment and the coupling constants of the two
doublets were different (6.5 and 9.4 Hz). Therefore, it was clear that two broad singlets instead of
doublets were present; this led to the conclusion that the obtained powder was a mixture of 15α-OH
and 15β-OH isomers. Furthermore, analysis of the NOESY spectrum showed a strong correlation
between H-12 and H-1, suggesting a C-12S configuration (Figure 1). In addition, the optical inactivity
of the mixture indicated that it was a racemic mixture. Thus, the compounds were then identified
as 2-oxo-15α-hydroxy-18,19-dimethoxycarbonyl-15,16-epoxy-ent-cleroda-1(10),3,13(16),14-tetraen-20,
12-olide and 2-oxo-15β-hydroxy-18,19-dimethoxycarbonyl-15,16-epoxy-ent-cleroda-1(10),3,13(16),
14-tetraen-20,12-olide and two clerodane diterpenes not previously described, which were given
the trivial names crotonolins A (3) and B (4), respectively.
In addition to the genus Croton, clerodanes, a large group of bicyclic 20-carbon terpene compounds,
are also found in the genera Ajuga, Gymnocolea, Jateorhiza, Scutelaria, Teucrium, Tinospora and
Zuelania [17]. The distribution of clerodane diterpenes and their chemotaxonomic implications, as well
as biological activities, have been well-documented by Li et al. [17].
Compounds 1–10 were evaluated for their cytotoxicity against A549 (adenocarcinomic human
alveolar basal epithelial), MCF7 (human breast adenocarcinoma), PC3 (human prostate cancer) and
PNT2 (human normal prostate epithelium) cells. The concentrations which inhibited fifty percent
of cell growth after treatment with each compound are presented in Table 1. Doxorubicin was
used as a positive control, with IC50 ranging from 0.7 to 16.4 µM between the cell lines used.
Compounds 3–10 were inactive against the MCF7 cell line. Compounds 1 and 2 exhibited moderate
levels of cytotoxicity against both A549 and MCF7 cells with 1 being the most active with IC50 values
of 63.8 ± 13.8 and 136.2 ± 22.7 µM against A549 and MCF7 cells, respectively. The epimeric mixture 3
and 4 was moderately active against A549 and PC3 cells (IC50 = 128.6 ± 31.0 and 111.2 ± 2.9 µM,
respectively). All these compounds displayed reduced levels of cytotoxicity compared with those of
the corresponding crude extracts and fractions. Consistent with this finding, it has been demonstrated
previously that the cytotoxicity of an extract may be a consequence of the synergetic action of all the
compounds present in that extract and not due to the action of a single compound [29]. Moreover,
in a number of previous studies, several plant-derived clerodane diterpenes showed good cytotoxic
activity against various cancer cell lines [30–34].
3. Material and Methods
3.1. General
Chromatographic solvents were purchased from Fisher Scientific, Loughborough, UK, and used
without further purification. Silica gel (70–230 mesh) and silica gel 60H, purchased from Sigma-Aldrich,
Gillingham, Dorset, UK, were used for open column chromatography (CC) and vacuum liquid
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chromatography (VLC), respectively. Analytical TLC was carried out on 0.2 mm Sigel 60 F254 plates
(Merck, Darmstadt, Germany). Spots were visualized under short (254 nm) and long wavelengths
(366 nm), as well as by spraying them with a 1% anisaldehyde solution in aqueous H2SO4, followed by
heating to 105 ◦C for 5 min. The NMR spectroscopic analyses were performed on a Bruker AMX600
NMR spectrometer, Coventry, UK (600 MHz for 1H, and 150 MHz for 13C). MS analyses were performed
on Xevo G2-S ASAP or LTQ Orbitrap XL 1 spectrometers, Swansea, UK. HPLC-DAD analysis was
performed on an Agilent 1260 Infinity series, Stockport, UK. Extracts and fractions were analyzed
on a Phenomenex Gemini-NX 5 U C18 column (150 × 4.6 mm, 5 µm, Phenomenex, Macclesfield, NC,
USA). An ACE preparative column (150 × 21.2 mm, 5 µm, Hichrom Ltd., Reading, UK) was used
for isolating compounds. A gradient 30–100% MeOH (0.1% TFA) was used in water over 30 min,
with a flow rate of 1 mL/min and 10 mL/min for analytical and preparative HPLC, respectively.
The column temperature was set at 25 ◦C. The chromatogram was used to monitor variable UV–Vis
wavelengths (215, 254, 280 and 320 nm). Optical rotation was determined using a Bellingham–Stanley
ADP660 polarimeter, Kent, UK (MeOH, c in g/100 mL). UV spectra were recorded on an Analytik
Jena Specord 210 spectrophotometer, Jena, Germany. IR spectra were recorded on an Agilent Cary 630
FT-IR, Stockport, UK.
3.2. Plant Material
The bark of Croton oligandrus Pierre ex Hutch. was collected from the Mount Eloundem, Centre
Region, Cameroon, in June 2015, and identified by Mr. Victor Nana, a retired taxonomist at the
Cameroon National Herbarium, where a voucher specimen (6687/SFR) was deposited.
3.3. Extraction and Isolation
The air-dried and ground bark (330.0 g) of C. oligandrus were extracted, successively, with
n-hexane, DCM and MeOH using a Soxhlet extractor (800 mL, 10 cycles each). After evaporation
at 40 ◦C under reduced pressure, 3.7 g, 2.6 g and 7.4 g of n-hexane, DCM and MeOH extracts were
obtained, respectively. The crude extracts were screened against three cancer cell lines: breast (MCF7),
prostate (PC3) and lung (A549) cancer cells. DCM and n-hexane extracts were found to be the most
active and were submitted to further fractionation using VLC. A portion of the n-hexane (3.3 g) and
DCM (2.2 g) extracts were adsorbed onto normal silica gel (70–230 mesh) and loaded on the top of
a VLC column pre-packed with silica gel 60H. A vacuum was applied and the column was eluted
with a stepwise gradient of mobile phase, consisting of an increasing amount of ethyl acetate (EA) in
n-hexane (Hex/EA 0%, 10%, 20%, 40%, 60% and 80%) or MeOH in DCM (DCM/MeOH 0%, 2%, 6%,
10%, 15% and 25%) for the n-hexane and DCM extracts, respectively, to obtain six different fractions.
The fractions were also screened against the cell lines cited above. Fractions H1, H2 and H4 of n-hexane
extract and D2, D3, D4, and D6 of DCM extracts showed potent cytotoxic activities and were subjected
to further purification. H2 (420.9 mg) of n-hexane extract was purified using a CC over silica gel to give
an equimolar mixture (18.2 mg) of 6 and 7, and acetyl aleuritolic acid 9 (4.4 mg). Lupeol 10 (6.1 mg) and
vanillin 8 (9.0 mg) were obtained from D4 by recrystallization. Ferulate derivatives, a mixture of 6 and
7 (3.2 mg), were obtained from F2 and F3 of the DCM crude extract by recrystallization. Preliminary 1H
NMR of the remaining filtrate showed that this latter was a mixture of lupeol and acetyl aleuritolic acid,
which was not purified further. D4 and D6 showed similar TLC and HPLC profiles and were mixed
together for purification. The mixture of the two fractions (783.0 mg) was purified by preparative
HPLC using an ACE Gemini-NX 5 U C18 column, Reading, UK (150 × 21.2 mm, Hichrom Ltd., UK),
flow rate 10 mL/min, mobile phase gradient of water (A) and methanol (B) both containing 0.1%
TFA: 30–100% B, 0–30 min; 100% B, 30–35 min; 100–30% B, 35–40 min, monitored at wavelengths of
254 and 280 nm to yield crotolins A (3) and B (4) (3.2 mg); 12-epi-megalocarpoidolide D (2) (6.8 mg),
megalocarpoidolide D (1) (9.2 mg), and crotocorylifuran (5) (8.2 mg) were purified with the retention
time (tR) 15.7, 18.8, 20.5 and 24.6 min, respectively.
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3.4. 12-epi-Megalocarpoidolide D (2)
White powder (6.8 mg); HRMS m/z 432.1650 [M + NH4]+ (calc. for C22H22O8NH4, 432.1653) in
positive ion mode; [α]25D + 81.7 (c 0.0018, MeOH); FT-IR (ATR) νmax 1715, 1767 and 1663 cm
−1. UV λmax
(MeOH) nm: 216, 224, 230, 252; see Table 2 for NMR data.
3.5. Crotonolins A and B (3 and 4)
White powder (3.2 mg); HRMS m/z 445.1142 [M−H]− (calc. for C22H21O10, 445.1140) in negative
ion mode; [α]25D 0.0 (c 0.009, MeOH); FT-IR (ATR) νmax 3465, 2932, 1775, 1712 and 1661 cm
−1; UV λmax
(MeOH) nm; 218, 222, 230, 252; see Table 2 for NMR data.
3.6. Cell Viability Assay
The in vitro activity of the crude extracts, fractions and isolated compounds from C. oligandrus on
metabolic cell viability was assessed against A549 (adenocarcinoma human alveolar basal epithelial
cell 211 line), MCF7 (human breast adenocarcinoma cell line), PC3 (human prostate cancer cell line)
and PNT2 212 (human normal prostate epithelium cell line). The resulting inhibitory activity is
termed “cytotoxic activity” throughout the manuscript. The cell lines were grown in RPMI medium
supplemented with L-glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 µg/mL) and 10% foetal
bovine serum (FBS) and cultured at 37 ◦C, 5% CO2 and 95% humidity. For experimental use, the cells
were seeded into 96-well plates (1.2 × 104/well) and incubated for 24 h. Cells were then treated with
crude extract (0–250 µg/mL) for 24 h or isolated compounds (0 to 200 µM) for 48 h and the cell viability
was measured using the MTT assay [35]. The formazan crystals formed were dissolved in DMSO and
optical density was read at 570 nm using a ClarioStar plate reader, Manchester, UK. Three individual wells
were assayed per treatment; the assay was repeated three times and cytotoxic activity was determined
using the percentage of absorbance compared to the control cells [(absorbance of treated cells/absorbance
of untreated cells) × 100]. Doxorubicin was used as the positive control and the IC50 value of each test
sample was calculated using the software Graphad Prism 7.02, La Jolla, CA, USA.
4. Conclusions
In the present study, crude extracts, fractions and isolated compounds from C. oligandrus
bark were evaluated for their cytotoxicity against a panel of cancer cells lines; A549, MCF7, PC3
and PNT2. Bioassay-guided isolation carried out on active fractions using a combination of open
column chromatography, recrystallization and preparative HPLC resulted in the identification of
new clerodane diterpenes, 12-epi-megalocarpoidolide D (2), crotonolins A (3) and B (4), together
with the known compounds megalocarpoidolide D (1), 12-epi-crotocorylifuran (5), cluytyl-ferulate
(6), hexacosanoyl-ferulate (7), vanillin (8), acetyl-aleuritolic acid (9) and lupeol (10). All tested
compounds, including the new clerodanes 2–4, were inactive or showed at best, a marginal level
of cytotoxicity against A549, MCF-7 and PC-3 cancer cells, but were also nontoxic to PNT2 normal
prostate epithelium cells.
Supplementary Materials: The spectra of new compounds (1–4) are available online.
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